Sources | Names Used |
---|---|
CCLE, GDSC1000 | PD-0325901 |
gCSI | pd0325901 |
PharmacoGx | PD-0325901 |
Database | Identifier |
---|---|
Smiles: | C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O |
Inchikey: | SUDAHWBOROXANE-SECBINFHSA-N |
Pubchem: | 9826528 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM129B | GDSC1000 | pan-cancer | AAC | 0.43 | 9e-17 |
mRNA | SPRY2 | CCLE | pan-cancer | AAC | 0.43 | 9e-21 |
mRNA | FAM129B | gCSI | pan-cancer | AAC | 0.43 | 7e-09 |
mRNA | PHLDA1 | gCSI | pan-cancer | AAC | 0.43 | 1e-11 |
mRNA | PON2 | gCSI | pan-cancer | AAC | 0.43 | 6e-10 |
mRNA | ACTN1 | gCSI | pan-cancer | AAC | 0.43 | 4e-10 |
mRNA | SFXN3 | gCSI | pan-cancer | AAC | 0.44 | 1e-14 |
mRNA | SLC35D2 | gCSI | pan-cancer | AAC | 0.46 | 2e-10 |
mRNA | SLC35D2 | CCLE | pan-cancer | AAC | 0.47 | 2e-16 |
mRNA | SPRY2 | gCSI | pan-cancer | AAC | 0.5 | 3e-16 |